Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track designation

Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track designation

Source: 
Endpoints
snippet: 

Vanda Pharmaceuticals is making a name for itself, at least in terms of suing the FDA.

The DC-headquartered firm on Monday filed its latest suit against the agency, with the company raising concerns over the FDA’s failure to grant a fast track designation for Vanda’s potential chronic digestive disorder drug tradipitant, which is a neurokinin 1 receptor antagonist.